Illumina, Inc. · NASDAQ:ILMN

Illumina — Conference Presentation (2014)

89 slides from Illumina's conference presentation, 2014

  1. Slide 1: Slide 1

  2. Slide 2: Postdoc / Senior technical officer (EMBL Heidelberg Bork group)

    • • Postdoc / Senior technical officer (EMBL Heidelberg Bork group) •

  3. Slide 3: Metabolic pathway

    Metabolic pathway http://www.kegg.jp/

  4. Slide 4: Slide 4

  5. Slide 5: Nature, Volume 464 Number 7285

    Nature, Volume 464 Number 7285

  6. Slide 6: 1. 2. 3.

    1. 2. 3.

  7. Slide 7: 2 kg 100T cells

    2 kg 100T cells

  8. Slide 8: Slide 8

  9. Slide 9: DGGE

    DGGE http://en.wikipedia.org/wiki/Community_Fingerprinting

  10. Slide 10: T-RFLP

    T-­‐RFLP http://nodens.ceab.csic.es/t-rfpred/method

  11. Slide 11: DNA sequencing history, 2004

    2004 atgaaacgcatta gcaccaccattac caccaccatcacc attaccacaggta acggtgcgggct J.C. Venter et al, Science, vol. 304, no. 5667, pp. 66–74, 2004.

  12. Slide 12: DNA

    atgaaacgcatta gcaccaccattac caccaccatcacc attaccacaggta acggtgcgggct DNA

  13. Slide 13: Slide 13

  14. Slide 14: Japanese_01

    Japanese_01 Atneritdm Ot SpanishgOe

  15. Slide 15: DNA

    atgaaacgcatta gcaccaccattac caccaccatcacc attaccacaggta acggtgcgggct DNA

  16. Slide 16: Analysis workflow

    te 1 By ZUR Wi Aa— Bee keenunes HUT IL NABI 1. BERIc Sibi 2 nea DNABCR DNABd5I) 4 -SOAPdonevo2 2 Metaveve! 3.1DBAUD WEFT R: 1. MeiaCenehrnotator 2! MetaGeneMark RTF: 1. 16s 2, Universal ‘ingle cooy gene ots Bare Keo cog RATT T tax tovel I sequencing depth FARR SamMIh: | BOAR NSRR UT BR WXs7—sLE ERED

  17. Slide 17: Analysis workflow

    Rte 1 By ZUR Wi Aa— Bee keenunes HUT IL BNABRE 1. BERIc Sibi 2 nea PCR ARaRRE: SAI 2.vivs posy yy) Vlumina 2. lon Prete 3.454 Rech: DNABCA DNABC5I) Peasy 4 -SOAPdonevo2 2 Metaveves ‘SripBAUO 2! MetaGeneMark Bare Keo cog WicAZy REE FARR SamMIh: | BOAR NSRR UT BR WXs7—sLE ERED ignewen ® PACT el |. FIV

  18. Slide 18: 16S rRNA gene

    16S rRNA gene 0 500 1000 1500 bp 1 ee ee CO RR: S< OLDE CHIRGEORU RR EE FRR: HEOLMEPT OME CHA ORR

  19. Slide 19: • • • •

    • • • •

  20. Slide 20: Analysis workflow

    Rte 1 By ZUR Wi Aa— Bee keenunes HUT IL BNABRE 1. BERIc Sibi 2 nea PCR ARaRRE: SAI 2.vivs posy yy) Vlumina 2. lon Prete 3.454 Rech: DNABCA DNABC5I) Peasy 4 -SOAPdonevo2 2 Metaveves ‘SripBAUO 2! MetaGeneMark Bare Keo cog WicAZy REE FARR SamMIh: | BOAR NSRR UT BR WXs7—sLE ERED ignewen ® PACT el |. FIV

  21. Slide 21: Metagenome sequencing

    Metagenome sequencing http://catalog.takara-bio.co.jp/

  22. Slide 22: DNA

    • • DNA • •

  23. Slide 23: Analysis workflow

    Rte 1 By ZUR Wi Aa— Bee keenunes HUT IL BNABRE 1. BERIc Sibi 2 nea PCR ARaRRE: SAI 2.vivs posy yy) Vlumina 2. lon Prete 3.454 Rech: DNABCA DNABC5I) Peasy 4 -SOAPdonevo2 2 Metaveves ‘SripBAUO 2! MetaGeneMark Bare Keo cog WicAZy REE FARR SamMIh: | BOAR NSRR UT BR WXs7—sLE ERED ignewen ® PACT el |. FIV

  24. Slide 24: Sequencing platforms: Illumina, Life Technologies

    Ilumina Miseq, Hiseq Life technologies Ion proton, Ion PGM

  25. Slide 25: Illumina MiSeq

    Illumina Miseq Output Read Number Read Length 15 Gb 25m 2x300 bp

  26. Slide 26: DNA

    atgaaacgcatta gcaccaccattac caccaccatcacc attaccacaggta acggtgcgggct DNA

  27. Slide 27: Analysis workflow

    1 By ZUR Wi Aa— Bee keenunes NABI 1. BERIc Sibi 2 nea DNAs Gi: 2 yoy: Tilmna 2. lon Proton 3454 Recha Peasy 4 -SOAPdonevo2 2 Metaveve! 3.1DBAUD WEFT R: 1. MeiaCenehrnotator 2! MetaGeneMark RTF: 1. 16s 2, Universal ‘ingle cooy gene 37 Bare Keo cog RATT T tax tovel I sequencing depth Sama: | BOAR NSRR

  28. Slide 28: •

    •

  29. Slide 29: Slide 29

  30. Slide 30: Analysis workflow

    1 By ZUR Wi Aa— Bee keenunes NABI 1. BERIc Sibi 2 nea DNAs Gi: 2 yoy: Tilmna 2. lon Proton 3454 Recha Peasy 4 -SOAPdonevo2 2 Metaveve! 3.1DBAUD WEFT R: 1. MeiaCenehrnotator 2! MetaGeneMark RTF: 1. 16s 2, Universal ‘ingle cooy gene 37 Bare Keo cog RATT T tax tovel I sequencing depth Sama: | BOAR NSRR

  31. Slide 31: Soap de novo 2 / Velvet / IDBA-UD

    • Soap de novo 2 / Velvet / IDBA-­‐UD •

  32. Slide 32: MetaGeneMark / MetaGeneAnnotator

    • MetaGeneMark / MetaGeneAnnotator A

  33. Slide 33: Analysis workflow

    1 By ZUR Wi Aa— Bee keenunes NABI 1. BERIc Sibi 2 nea DNAs Gi: 2 yoy: Tilmna 2. lon Proton 3454 Recha Peasy 4 -SOAPdonevo2 2 Metaveve! 3.1DBAUD WEFT R: 1. MeiaCenehrnotator 2! MetaGeneMark RTF: 1. 16s 2, Universal ‘ingle cooy gene 37 Bare Keo cog RATT T tax tovel I sequencing depth Sama: | BOAR NSRR

  34. Slide 34: Whole genome vs 16S rRNA

    • Whole • 16SrRNA • • • •

  35. Slide 35: Slide 35

  36. Slide 36: Slide 36

  37. Slide 37: Slide 37

  38. Slide 38: Slide 38

  39. Slide 39: Enterotype principal component plot

    Veillonella Catenibacterium Alkaliphilus Akkermansia Helicobacter Geobacter ● JP.AD.7 Leuconostoc Bacteroides Ruminococcaceae Staphylococcus Bacteroides Parabacteroides Prevotella JP.AD.1 Eggerthella Peptostrepto coccaceae ● ●JP.AD.9 Clostridiales Desulfovibrio Holdemania ● FR.AD.3 Lactobacillus ● J

  40. Slide 40: Enterotype principal component plot

    Veillonella Catenibacterium Alkaliphilus Akkermansia Helicobacter Geobacter ● JP.AD.7 Leuconostoc Bacteroides Ruminococcaceae Staphylococcus Bacteroides Parabacteroides Prevotella JP.AD.1 Eggerthella Peptostrepto coccaceae ● ●JP.AD.9 Clostridiales Desulfovibrio Holdemania ● FR.AD.3 Lactobacillus ● J

  41. Slide 41: Enterotype principal component plot

    Veillonella Catenibacterium Alkaliphilus Akkermansia Helicobacter Geobacter ● JP.AD.7 Leuconostoc Bacteroides Ruminococcaceae Staphylococcus Bacteroides Parabacteroides Prevotella JP.AD.1 Eggerthella Peptostrepto coccaceae ● ●JP.AD.9 Clostridiales Desulfovibrio Holdemania ● FR.AD.3 Lactobacillus ● J

  42. Slide 42: Large-scale gut metagenome studies

    2011 2014 124 330 1267 1,000 Junhua Li et al, Nature Biotechnology 32, 834–841 (2014) Junjie Qin et al, Nature 464, 59-65 (4 March 2010)

  43. Slide 43: Analysis workflow

    1 By ZUR Wi Aa— Bee keenunes NABI 1. BERIc Sibi 2 nea DNAs Gi: 2 yoy: Tilmna 2. lon Proton 3454 Recha Peasy 4 -SOAPdonevo2 2 Metaveve! 3.1DBAUD WEFT R: 1. MeiaCenehrnotator 2! MetaGeneMark RTF: 1. 16s 2, Universal ‘ingle cooy gene 37 Bare Keo cog RATT T tax tovel I sequencing depth Sama: | BOAR NSRR

  44. Slide 44: Gut bacteria associated with disease

    • → Emmanuelle Le Chatelier et al, Nature 500,541–546(29 August 2013) • → Junjie Qin et al, Nature 490,55–60 (4 October 2012) • → Bacteroides fragilis, Fusobacterium Nucleatum Zeller G et al, Mol Syst Biol. 2014 Nov 28;

  45. Slide 45: SCFA

    -­‐> SCFA

  46. Slide 46: 1. 2. 3.

    1. 2. 3.

  47. Slide 47: SCFA

    -­‐> SCFA

  48. Slide 48: Symbiotic relationship and intestinal flora balance

    Symbiotic relationship Pathogenicity Balance of intestinal flora Bacterial counts per gram feces 10*-10" 108-108 0-10¢ Bacterial group Bacteroides Eubacteria Anaerobic streptococci Bifidobacteria Escherichia coli Streptococci Lactobacilli Veillonella Proteus Pseudomonas aeruginosa AMPH 193% 2005 Fun

  49. Slide 49: Stool samples from HMP

    139 stool samples from HMP enzymes, 1914468 other proteins, 13092134 Data from “A framework for human microbiome research. Nature 486, 215–21 (2012).”

  50. Slide 50: Enzyme ratio in 2800 genomes

    Enzyme ra\o in 2800 genomes 70 60 50 Enzyme Raio/ % 40 30 20 10 0 0 2000 4000 6000 8000 10000 12000 Protein Number

  51. Slide 51: Stool samples from HMP

    139 stool samples from HMP enzymes, 1914468 ? other proteins, 13092134 Data from “A framework for human microbiome research. Nature 486, 215–21 (2012).”

  52. Slide 52: Slide 52

  53. Slide 53: SCFA

    -­‐> SCFA

  54. Slide 54: HMP

    HMP enzymes, 1914468 ? other proteins, 13092134 Data from “A framework for human microbiome research. Nature 486, 215–21 (2012).”

  55. Slide 55: Curcumin, Dihydrocurcumin, Tetrahydrocurcumin

    • • – – – Curcumin – – Dihydrocurcumin Tetrahydrocurcumin

  56. Slide 56: Curcumin medicinal properties

    Curcumin has a range of medicinal properties including antioxidant, anti-inflammatory, anticancer and analgesic. Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6615-20.

  57. Slide 57: Curcumin metabolic pathway

    Curcumin has a range of medicinal properties including antioxidant, anti-inflammatory, anticancer and analgesic. Discovery of the curcumin metabolic pathway involving a Curcumin unique enzyme in an intestinal microorganism. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6615-20. Dihydrocurcumin Tetra

  58. Slide 58: Curcumin metabolic pathway

    Curcumin has a range of medicinal properties including antioxidant, anti-inflammatory, anticancer and analgesic. Discovery of the curcumin metabolic pathway involving a Curcumin unique enzyme in an intestinal microorganism. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6615-20. Dihydrocurcumin Tetra

  59. Slide 59: Curcumin metabolic pathway

    Curcumin has a range of medicinal properties including antioxidant, anti-inflammatory, anticancer and analgesic. Discovery of the curcumin metabolic pathway involving a Curcumin unique enzyme in an intestinal microorganism. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6615-20. GI:327134017 Dihydroc

  60. Slide 60: mit a

    - HL mit a ttt)

  61. Slide 61: Food, Drug, Secretion

    Food Drug Secretion Others

  62. Slide 62: EnteroPathway reactions and modules

    EnteroPathway KEGG Total Gene known Gene unknown Reac\ons 59 343 2411 2813 Modules 136 217 353 2014/5/23!

  63. Slide 63: •

    •

  64. Slide 64: Secretion

    Secretion

  65. Slide 65: 1. 2. 3.

    1. 2. 3.

  66. Slide 66: EnteroPathway reactions and modules

    EnteroPathway KEGG Total Gene known Gene unknown Reac\ons 59 + 78 265 2411 2813 Modules 136 217 353 2014/5/23!

  67. Slide 67: Future works

    Future works • – • Web tool

  68. Slide 68: 1. 2. 3.

    1. 2. 3.

  69. Slide 69: Japanese Consortium for Human Microbiome

    Japanese Consortium for Human Micro! “=A JCHMOZ3EA a —7 Japanese Consortium for Human Microbiome

  70. Slide 70: 130

    130

  71. Slide 71: Slide 71

  72. Slide 72: Slide 72

  73. Slide 73: Slide 73

  74. Slide 74: Cloud sourcing, Cloud funding

    a large scale scientific study open to everyone Cloud sourcing, Cloud funding = http://my.microbes.eu/

  75. Slide 75: my.microbes.eu

    • 1000 • http://my.microbes.eu/

  76. Slide 76: epee

    a , epee HAAMAMMOSSAE ZOERGHISYbIt—L |

  77. Slide 77: Slide 77

  78. Slide 78: Peer Bork@EMBL & SFR

    Peer Bork@ttc & SFR

  79. Slide 79: Analysis approach

    • – – DNA – • (16S) – In house • – – – KEGG/COG/CAZy

  80. Slide 80: BBG Y TILBH/IN—hF— (Bee BA)

    1 BBG Y TILBH/IN—hF— (Bee BA) on ‘om CARR, ARRIBNBE)

  81. Slide 81: ABPDATFTOVYIIb

    ABPDATFTOVYIIb EMAAR YZ DATASRAE 1S @ (USAR Y 2) LA $e) (RTA) th LARA RITOYIIb ON AHIR LEE $B) GRISEA) My.microbes FOYI7b Ste (RRIZAFRS) WR ha) (RTA)

  82. Slide 82: 5000

    = 5000

  83. Slide 83: ?

    ?

  84. Slide 84: ? ! ! !

    ? ! ! !

  85. Slide 85: =

    =

  86. Slide 86: Japanese Consortium for Human Microbiome

    Japanese Consortium for Human Micro! “=A JCHMOZ3EA a —7 Japanese Consortium for Human Microbiome

  87. Slide 87: www.jchm.jp

    www.jchm.jp

  88. Slide 88: jchm

    Japan jchm

  89. Slide 89: DBCLS, EMBL, Peer Bork

    DBCLS EMBL Peer Bork

Illumina — Conference Presentation (2014) on 6ix